Literature DB >> 31043477

Identification and Structure of an MHC Class I-Encoded Protein with the Potential to Present N-Myristoylated 4-mer Peptides to T Cells.

Yukie Yamamoto1,2, Daisuke Morita1,2, Yoko Shima1,2, Akihiro Midorikawa1,2, Tatsuaki Mizutani1,2, Juri Suzuki3, Naoki Mori4, Takashi Shiina5, Hidetoshi Inoko5, Yoshimasa Tanaka6, Bunzo Mikami7, Masahiko Sugita8,2.   

Abstract

Similar to host proteins, N-myristoylation occurs for viral proteins to dictate their pathological function. However, this lipid-modifying reaction creates a novel class of "lipopeptide" Ags targeted by host CTLs. The primate MHC class I-encoded protein, Mamu-B*098, was previously shown to bind N-myristoylated 5-mer peptides. Nevertheless, T cells exist that recognize even shorter lipopeptides, and much remains to be elucidated concerning the molecular mechanisms of lipopeptide presentation. We, in this study, demonstrate that the MHC class I allele, Mamu-B*05104, binds the N-myristoylated 4-mer peptide (C14-Gly-Gly-Ala-Ile) derived from the viral Nef protein for its presentation to CTLs. A phylogenetic tree analysis indicates that these classical MHC class I alleles are not closely associated; however, the high-resolution x-ray crystallographic analyses indicate that both molecules share lipid-binding structures defined by the exceptionally large, hydrophobic B pocket to accommodate the acylated glycine (G1) as an anchor. The C-terminal isoleucine (I4) of C14-Gly-Gly-Ala-Ile anchors at the F pocket, which is distinct from that of Mamu-B*098 and is virtually identical to that of the peptide-presenting MHC class I molecule, HLA-B51. The two central amino acid residues (G2 and A3) are only exposed externally for recognition by T cells, and the methyl side chain on A3 constitutes a major T cell epitope, underscoring that the epitopic diversity is highly limited for lipopeptides as compared with that for MHC class I-presented long peptides. These structural features suggest that lipopeptide-presenting MHC class I alleles comprise a distinct MHC class I subset that mediates an alternative pathway for CTL activation.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31043477     DOI: 10.4049/jimmunol.1900087

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

Review 1.  N-Myristoyltransferase as a Glycine and Lysine Myristoyltransferase in Cancer, Immunity, and Infections.

Authors:  Tatsiana Kosciuk; Hening Lin
Journal:  ACS Chem Biol       Date:  2020-06-10       Impact factor: 5.100

2.  SARS-CoV-2-Induced Immunosuppression: A Molecular Mimicry Syndrome.

Authors:  Darja Kanduc
Journal:  Glob Med Genet       Date:  2022-07-14

3.  Crystal structures of lysophospholipid-bound MHC class I molecules.

Authors:  Yoko Shima; Daisuke Morita; Tatsuaki Mizutani; Naoki Mori; Bunzo Mikami; Masahiko Sugita
Journal:  J Biol Chem       Date:  2020-04-08       Impact factor: 5.157

Review 4.  Structural aspects of chemical modifications in the MHC-restricted immunopeptidome; Implications for immune recognition.

Authors:  Tatyana Sandalova; Benedetta Maria Sala; Adnane Achour
Journal:  Front Chem       Date:  2022-08-09       Impact factor: 5.545

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.